Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations
- 1 March 2002
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 30 (3) , 541-547
- https://doi.org/10.1097/00003246-200203000-00008
Abstract
Determine the significance of recovering yeasts from intraoperative specimens from the abdominal cavity and to evaluate the effect of a single intraoperative dose of fluconazole on clinical outcome in patients with intra-abdominal perforations. Prospective, randomized, double-blind study. Multicenter study from 13 hospitals in Norway. One hundred nine patients with intra-abdominal perforations. Patients were randomized to receive either a single 400-mg fluconazole dose or placebo during the operation. An intra-abdominal specimen for microbiological culture was obtained at the time of the operation. The primary response variable in the study was death. Secondary response variables were three parameters indicating a complicated postoperative period: mechanical ventilation for ≥5 days, intensive care treatment for ≥10 days, and use of a central venous catheter for ≥10 days. Yeasts were recovered from a intraoperative intra-abdominal specimen from only 1 (3.5%) of 28 patients with perforated appendicitis and from 32 (39.5%) of 81 nonappendicitis patients. Excluding the appendicitis patients, the yeast recovery rate was high both for patients hospitalized at the time of the perforation (45%) and for nonhospitalized patients (32%). The overall mortality was 11% (12 patients). Single-dose intraoperative fluconazole prophylaxis did not reach a statistically significant effect on mortality (4 of 53 patients in the fluconazole group and 8 of 56 patients in the placebo group died [p = .059]). The only two explanatory variables significantly related to death were a intraoperative finding of yeast from an intra-abdominal specimen and the occurrence of a spontaneous perforation in a patient already hospitalized for nonsurgical cancer treatment. Detection of yeast was also a significant explanatory variable for a prolonged period of mechanical ventilation, intensive care treatment, and prolonged use of a central venous catheter. Single-dose intraoperative fluconazole prophylaxis did not have a statistically significant effect on overall mortality (odds ratio = 0.21; 95% confidence interval, 0.04–1.06;p = .059) in patients with intra-abdominal perforation. The recovery rate of yeast from intraoperative specimens from the abdominal cavity was high (>30%) and was associated with death and a complicated postoperative course.Keywords
This publication has 31 references indexed in Scilit:
- Preventing intra-abdominal candidiasis in surgical patientsCritical Care Medicine, 1999
- Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patientsCritical Care Medicine, 1999
- Constant Low Rate of Fungemia in Norway, 1991 to 1996Journal of Clinical Microbiology, 1998
- Antibiotic Therapy for Abdominal InfectionWorld Journal of Surgery, 1998
- Candida norvegensis: a fluconazole-resistant speciesAntimicrobial Agents and Chemotherapy, 1997
- Peritonitis: Update on Pathophysiology, Clinical Manifestations, and ManagementClinical Infectious Diseases, 1997
- Fungal infection in surgical patientsThe American Journal of Surgery, 1996
- Intraabdominal Infection: A ReviewClinical Infectious Diseases, 1994
- Antibiotic Treatment for Surgical PeritonitisAnnals of Surgery, 1991
- CLINICAL SIGNIFICANCE OF CANDIDA ISOLATED FROM PERITONEUM IN SURGICAL PATIENTSThe Lancet, 1989